Tianyin Pharma Forms JV with Buchang Pharma

Tianyin Pharma will form a Joint Venture with Buchang Pharmaceutical to increase China distribution of its modernized formulations of traditional Chinese medicines. In return for a 95% stake in the JV, Tianyin will contribute its portfolio of TCM products and its newly completed production facility in Qionglai. which constitute the JV's registered capital of $33 million. If Buchang added any capital for its 5% ownership of the JV, it wasn't disclosed. More details.... Stock Symbol:(NYSE: TPI) Share this with colleagues: // //